Otonomy Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Back to Jobs

Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO , Aug. 08, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today reported financial results for the quarter ended June 30, 2018 and

Apply Now